Home » Topics » BioWorld Science

BioWorld Science
RSS

Alliance signed for asthma disease management program

Aug. 9, 1996

Hoechst Marion Roussel receives marketing approval for Allegra

Aug. 9, 1996

Neurex's SNX-111 progresses through clinical trials

Aug. 9, 1996

NMPA and/or AMPA antagonists from Warner-Lambert

Aug. 9, 1996

Sandoz's Exelon shows positive results in phase III

Aug. 9, 1996

NMDA antagonists claimed by E. Merck

Aug. 9, 1996

Dainippon's new compound superior to metoclopramide for digestive function improvement

Aug. 9, 1996

Teva's Copaxone progresses toward FDA approval

Aug. 9, 1996

Health-Mark Diagnostics is now wholly owned by TCPI

Aug. 9, 1996

Resource Biometrics acquired by IBAH

Aug. 9, 1996

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...